Gulf War 1 Veteran Healthcare Satisfaction

Persian Gulf War Syndrome in Veteran Clinical Trial

Official title:

Gulf War 1 Veteran Patient Satisfaction With VA Primary Care: A Survey Study.

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT01703767
• Other study ID #: IRB_00053707
• Status: Withdrawn
• Phase: N/A
• First received: October 5, 2012
• Last updated: August 10, 2016
• Start date: October 2014
• Est. completion date: October 2015

Study information

• Verified date: August 2016
• Source: University of Utah
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to investigate Gulf War 1 Veteran (GW1V) patient perceptions of, and satisfaction with, their VA primary care treatment, and physician effectiveness in delivering improved point of service, in the Primary Care Clinics at the Veterans Administration (VA) Salt Lake City Health Care System.

Description:

Veterans of the 1990-1991 Gulf War1 (GW1) conflict are still experiencing a host of adverse health conditions at the present time. Many GW1 Veterans are still unhappy with their health care at the VA, and other stakeholders are critical of how the VA has dealt with GW1 Veterans' issues. For these reasons, the Gulf War Veterans' Illness Task Force (GWVI-TF) was set up to find ways to improve the situation.

The present survey study addresses one of GWVI-TF's missions, that is, to identify gaps in VA services, and to discover opportunities to better serve GW1V. Caring for GW1V is a top priority for VA health care providers, which is all the more pressing for the following reasons: 1. medical science of Gulf War Illness and environmental exposures is still at its infancy, 2. most providers have not received any focused education about how to take care of GW1V and the unique medical problems these veterans face, 3. a lack of provider knowledge that GW1V may receive may lead to decreased satisfaction on the part of GW1V and may result in GW1V perceived health service quality that is compromised.

In this pilot study, we focus on #2 and #3, to determine how we may understand veterans' perceptions of their medical treatment to ultimately improve GW1V medical health outcomes.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: October 2015
• Est. primary completion date: July 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 38 Years to 80 Years

Eligibility

Inclusion Criteria:

• a gulf war Veteran who served during the Persian Gulf War (GW1) of 1990-1991

• currently treated by a primary care physician at the VASLCHCS

Exclusion Criteria:

• cannot read and write English

Study Design

Observational Model: Case Control, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Persian Gulf Syndrome
• Persian Gulf War Syndrome in Veteran

Intervention

Behavioral:
• Provider Education Workshop
Educational resources for physicians regarding the needs of GW1V patients.

Locations

Country	Name	City	State
United States	University of Utah	Salt Lake City	Utah
United States	VA SLC Health Care System	Salt Lake City	Utah

Sponsors (2)

Lead Sponsor	Collaborator
University of Utah	VA Salt Lake City Health Care System

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Client Satisfaction score	The Client Satisfaction Questionnaire will be used to measure change in client satisfaction at baseline and after providers have received Provider Education Workshop training	baseline and 3 months	No
Primary	Change in Patient Satisfaction score	The Patient Satisfaction Questionnaire will be used to measure change in patient satisfaction at baseline and after providers have received Provider Education Workshop training	baseline and 3 months	No
Secondary	Change in Physician Assessment of GW1V Care	The Physician Survey will be used to measure change in physician assessment of GW1V care at baseline and after providers have received Provider Education Workshop training.	Baseline and 3 months	No